Search Results for keywords:"Sterling Pharma USA LLC"

Found 2 results
Skip to main content

Search Results: keywords:"Sterling Pharma USA LLC"

  • Type:Notice
    Citation:90 FR 12367
    Reading Time:about a minute or two

    Sterling Pharma USA LLC has applied to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of controlled substances. This application, filed on February 11, 2025, aims to support the company's internal research and provide substances for pre-clinical trial studies. The public can comment or object to this registration until May 16, 2025, through the Federal eRulemaking Portal.

    Simple Explanation

    Sterling Pharma USA wants permission to make special medicines and asked the DEA to approve this. People can tell the DEA what they think about this until May 16, 2025.

  • Type:Notice
    Citation:86 FR 8381
    Reading Time:less than a minute

    The Drug Enforcement Administration (DEA) has announced that Sterling Pharma USA LLC has submitted an application to become a bulk manufacturer of controlled substances. Specifically, they plan to produce Tetrahydrocannabinols from hemp extract. People who are currently registered as bulk manufacturers of these substances, or who are applying to be, have the opportunity to file comments or objections regarding this application by April 6, 2021. They can also request a hearing before the same deadline.

    Simple Explanation

    Sterling Pharma USA wants to make some special medicines and has asked for permission from the government. Other companies who also make these medicines can say what they think about this by April 6, 2021.